Property:Current cancer therapy
This is a property of type Text.
The allowed values for this property are:
- Active surveillance
- Chemotherapy
- Hormone therapy
- Immunotherapy
- Radiation therapy
- Radioiodine treatment
- Stem cell or bone marrow transplant
- Surgery
- Targeted therapy
- Diverse
- No therapy
- NI
- ?
V
Radiation therapy +
Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy +
Chemotherapy +
W
Walsh et al. (2010): Use of alpha,25-dihydroxyvitamin D3 treatment to stimulate immune infiltration into head and neck squamous cell carcinoma +
Surgery +
Williams et al. (1996): Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity +
? +
Wrbka et al. (1987): Unterstützung der Chemotherapie inoperabler Karzinome durch proteolytische Fermente +
Chemotherapy +
Y
Yap et al. (2017): Predictors of hand-foot syndrome and pyridoxine for prevention of capecitabine-induced hand-foot syndrome: a randomized clinical trial +
Chemotherapy +
Z
Zalat et al. (2020): Evaluation of the cardioprotective effects of l-carnitine and silymarin in cancer patients receiving anthracycline-containing chemotherapy +
Chemotherapy +
Zick et al. (2008): Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting +
Chemotherapy +
Ö
{ "type": "PROPERTY_CONSTRAINT_SCHEMA", "constraints": { "type_constraint": "_txt", "allowed_values": [ "Surgery", "Chemotherapy", "Immunotherapy", "?", "NI", "Diverse", "Active surveillance", "Hormone therapy", "Radiation therapy", "Stem cell or bone marrow transplant", "Targeted therapy", "No therapy", "Radioiodine treatment" ] } }